Heartland Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.21M Sell
46,986
-1,277
-3% -$248K 0.47% 81
2025
Q4
$8.38M Sell
48,263
-1,744
-3% -$318K 0.45% 85
2025
Q3
$9.53M Sell
50,007
-1,588
-3% -$282K 0.5% 79
2025
Q2
$9.27M Sell
51,595
-50,877
-50% -$8.84M 0.52% 77
2025
Q1
$17.3M Sell
102,472
-52,729
-34% -$8.66M 1% 22
2024
Q4
$23.4M Sell
155,201
-9,169
-6% -$1.43M 1.27% 11
2024
Q3
$25.5M Sell
164,370
-63,596
-28% -$9.5M 1.34% 9
2024
Q2
$31.2M Buy
227,966
+19,348
+9% +$2.65M 1.75% 4
2024
Q1
$27.8M Buy
208,618
+441
+0.2% +$57.2K 1.46% 7
2023
Q4
$28.7M Buy
208,177
+55,995
+37% +$7.36M 1.5% 7
2023
Q3
$18.5M Buy
152,182
+12,007
+9% +$1.6M 1.04% 15
2023
Q2
$19.7M Buy
140,175
+47,997
+52% +$6.62M 1.13% 14
2023
Q1
$13M Sell
92,178
-2,778
-3% -$397K 0.81% 37
2022
Q4
$14.9M Buy
94,956
+10,650
+13% +$1.53M 0.94% 25
2022
Q3
$10.3M Buy
84,306
+6,226
+8% +$820K 0.77% 41
2022
Q2
$10.4M Buy
78,080
+6,721
+9% +$916K 0.72% 49
2022
Q1
$9.77M Sell
71,359
-117
-0.2% -$16.3K 0.61% 63
2021
Q4
$12.4M Sell
71,476
-16,513
-19% -$2.51M 0.72% 42
2021
Q3
$12.8M Sell
87,989
-47,094
-35% -$6.89M 0.77% 32
2021
Q2
$17.8M Buy
135,083
+10,506
+8% +$1.38M 1.03% 14
2021
Q1
$16M Buy
124,577
+43,256
+53% +$5.33M 1.01% 15
2020
Q4
$9.69M Sell
81,321
-9,092
-10% -$1.11M 0.69% 46
2020
Q3
$10.4M Buy
90,413
+4,628
+5% +$547K 0.9% 26
2020
Q2
$9.78M Sell
85,785
-22,967
-21% -$2.44M 0.87% 28
2020
Q1
$8.73M Buy
108,752
+19,334
+22% +$2M 0.93% 30
2019
Q4
$9.55M Sell
89,418
-22,889
-20% -$2.39M 0.7% 57
2019
Q3
$12M Sell
112,307
-17,987
-14% -$1.85M 0.92% 28
2019
Q2
$13.3M Sell
130,294
-104
-0.1% -$9.99K 0.98% 24
2019
Q1
$11.7M Buy
130,398
+44,724
+52% +$3.88M 0.87% 34
2018
Q4
$7.13M Buy
85,674
+10,199
+14% +$956K 0.59% 79
2018
Q3
$8.14M Sell
75,475
-474
-0.6% -$52K 0.54% 84
2018
Q2
$8.35M Sell
75,949
-6,322
-8% -$659K 0.55% 79
2018
Q1
$8.25M Sell
82,271
-1,120
-1% -$115K 0.55% 76
2017
Q4
$8.21M Buy
83,391
+1,897
+2% +$180K 0.53% 90
2017
Q3
$7.63M Sell
81,494
-20,900
-20% -$2.22M 0.49% 102
2017
Q2
$11.4M Sell
102,394
-41,021
-29% -$4.34M 0.73% 48
2017
Q1
$14.1M Sell
143,415
-39,782
-22% -$3.79M 0.86% 22
2016
Q4
$16.8M Buy
183,197
+319
+0.2% +$27.5K 0.93% 24
2016
Q3
$15.5M Sell
182,878
-36,133
-16% -$3.03M 0.89% 27
2016
Q2
$17.8M Sell
219,011
-4,543
-2% -$346K 1% 19
2016
Q1
$16M Sell
223,554
-82,871
-27% -$5.56M 0.84% 33
2015
Q4
$21.8M Sell
306,425
-36,007
-11% -$2.42M 0.87% 29
2015
Q3
$21M Sell
342,432
-29,817
-8% -$2.08M 0.77% 36
2015
Q2
$27M Sell
372,249
-49,053
-12% -$3.62M 0.75% 35
2015
Q1
$32.4M Sell
421,302
-54,759
-12% -$3.92M 0.81% 36
2014
Q4
$31.9M Buy
476,061
+9,350
+2% +$590K 0.63% 55
2014
Q3
$28.3M Sell
466,711
-3,106
-0.7% -$191K 0.55% 63
2014
Q2
$27.6M Sell
469,817
-44,264
-9% -$2.59M 0.48% 75
2014
Q1
$29.8M Sell
514,081
-2,495
-0.5% -$134K 0.52% 64
2013
Q4
$27.7M Buy
516,576
+78,743
+18% +$4.67M 0.48% 79
2013
Q3
$27.1M Buy
437,833
+1,731
+0.4% +$104K 0.49% 74
2013
Q2
$26.4M Buy
+436,102
New +$26M 0.49% 84

Other funds holding DGX

Heartland Advisors's DGX Position: Q1 2026 in Review

Heartland Advisors reduced its Quest Diagnostics (DGX) stake by 2.6% in Q1 2026, selling an estimated $248K and leaving 46,986 shares worth $9.21M. The position accounts for 0.47% of the portfolio, ranked #81.

Heartland Advisors first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.4M in Q1 2015. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Heartland Advisors held 46,986 shares of Quest Diagnostics worth $9.21M as of Q1 2026.
  • Heartland Advisors sold 1,277 Quest Diagnostics shares in Q1 2026, an estimated $248K.
  • Quest Diagnostics made up 0.47% of Heartland Advisors's portfolio in Q1 2026, its #81 holding.
  • Heartland Advisors first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Heartland Advisors's Quest Diagnostics position peaked at $32.4M in Q1 2015.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Heartland Advisors's 13F filing for Q1 2026, filed 6 May 2026.